![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print March 30, 2006
Medicine, Baylor college of Medicine, Houston, TX 77030
Corresponding Author: hamamori{at}bcm.edu
Rho-associated coiled-coil protein kinase, ROCK, is an effector for the small GTPase Rho, and plays a pivotal role in a diverse array of cellular activities including cell adhesion, cytokinesis and gene expression, primarily through an alteration of actin cytoskeleton dynamics. Here, we show that ROCK2 is localized in the nucleus, and associates with p300 acetyltransferase both in vitro and in cells. Nuclear ROCK2 is present in a large protein complex, and partially cofractionates with p300 by gel filtration analysis. By immuno- fluorescence, ROCK2 partially colocalizes with p300 in distinct insoluble nuclear structures. ROCK2 phosphorylates p300 in vitro, and nuclear-restricted expression of constitutively active ROCK2 induces p300 phosphorylation in cells. P300 acetyltransferase activity is dependent on its phosphorylation status in cells, and p300 phosphorylation by ROCK2 results in an increase in its acetyltransferase activity in vitro. These observations suggest that nuclear-localized ROCK2 targets p300 for phosphorylation to regulate its acetyl- transferase activity.
J. Biol. Chem, 10.1074/jbc.M510954200
Submitted on October 6, 2005
Revised on March 29, 2006
Accepted on March 30, 2006
Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Q. Wei, L. A. Shehadeh, J. M. Mitrani, M. Pessanha, T. I. Slepak, K. A. Webster, and N. H. Bishopric Quantitative Control of Adaptive Cardiac Hypertrophy by Acetyltransferase p300 Circulation, August 26, 2008; 118(9): 934 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanaka, H. Sato, H. Doi, C. A. Yoshida, T. Shimizu, H. Matsui, M. Yamazaki, H. Akiyama, K. Kawai-Kowase, T. Iso, et al. Runx2 Represses Myocardin-Mediated Differentiation and Facilitates Osteogenic Conversion of Vascular Smooth Muscle Cells Mol. Cell. Biol., February 1, 2008; 28(3): 1147 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Knock, Y. Shaifta, V. A. Snetkov, B. Vowles, S. Drndarski, J. P.T. Ward, and P. I. Aaronson Interaction between src family kinases and rho-kinase in agonist-induced Ca2+-sensitization of rat pulmonary artery Cardiovasc Res, February 1, 2008; 77(3): 570 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Stanley Insulin-Increased Prolactin Gene Expression Requires Actin Treadmilling: Potential Role for P21 Activated Kinase Endocrinology, December 1, 2007; 148(12): 5874 - 5883. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Grabocka and P. B. Wedegaertner Disruption of Oligomerization Induces Nucleocytoplasmic Shuttling of Leukemia-Associated Rho Guanine-Nucleotide Exchange Factor Mol. Pharmacol., October 1, 2007; 72(4): 993 - 1002. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |